These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 2140113)

  • 21. [Therapeutic alternative or 2d choice drug. Trisodium phosphonoformate in cytomegalovirus retinitis].
    Gümbel H; Ohrloff C; Schalnus R; Helm EB
    Fortschr Ophthalmol; 1991; 88(6):731-4. PubMed ID: 1665472
    [TBL] [Abstract][Full Text] [Related]  

  • 22. High performance liquid chromatography with an electrochemical detector in the cathodic mode as a tool for the determination of p-nitrophenol and assay of acid phosphatase in urine samples.
    Yamauchi Y; Ido M; Ohta M; Maeda H
    Chem Pharm Bull (Tokyo); 2004 May; 52(5):552-5. PubMed ID: 15133206
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Analysis of erythromycin in biological fluids by high-performance liquid chromatography with electrochemical detection.
    Chen ML; Chiou WL
    J Chromatogr; 1983 Nov; 278(1):91-100. PubMed ID: 6662889
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Micro-method for the determination of roxithromycin in human plasma and urine by high-performance liquid chromatography using electrochemical detection.
    Demotes-Mainaird FM; Vinçon GA; Jarry CH; Albin HC
    J Chromatogr; 1989 May; 490(1):115-23. PubMed ID: 2760144
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Antiviral activity of phosphonoacetic acid, phosphonopropionic acid, and trisodium phosphonoformate hexahydrate against herpesvirus hominis type 1 and type 2 in vitro].
    Thiel KD; Wutzler P; Sprössig M; Bertram D
    Pharmazie; 1982 Aug; 37(8):608. PubMed ID: 6292963
    [No Abstract]   [Full Text] [Related]  

  • 26. Foscarnet therapy for ganciclovir-resistant cytomegalovirus retinitis in patients with AIDS.
    Jacobson MA; Drew WL; Feinberg J; O'Donnell JJ; Whitmore PV; Miner RD; Parenti D
    J Infect Dis; 1991 Jun; 163(6):1348-51. PubMed ID: 1645385
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Quantitation of the antitumor agent N-(phosphonacetyl)-L-aspartic acid in human plasma and urine by gas chromatography-mass spectrometry-selected ion monitoring.
    Branfman AR; Bruni RJ; Merrill YN; Chadwick M; Strong JM; Ervin TJ
    J Chromatogr; 1980 May; 182(2):163-9. PubMed ID: 7380909
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Determination of a new bisphosphonate, YM175, in plasma, urine and bone by high-performance liquid chromatography with electrochemical detection.
    Usui T; Watanabe T; Higuchi S
    J Chromatogr; 1992 Dec; 584(2):213-20. PubMed ID: 1484106
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Foscarnet therapy of ganciclovir-resistant cytomegalovirus in marrow transplantation.
    Drobyski WR; Knox KK; Carrigan DR; Ash RC
    Transplantation; 1991 Jul; 52(1):155-7. PubMed ID: 1650043
    [No Abstract]   [Full Text] [Related]  

  • 30. Fixed drug eruption due to foscarnet.
    Connolly GM; Gazzard BG; Hawkins DA
    Genitourin Med; 1990 Apr; 66(2):97-8. PubMed ID: 2160425
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Pharmacokinetics and absorption of foscarnet after intravenous and oral administration to patients with human immunodeficiency virus.
    Sjövall J; Karlsson A; Ogenstad S; Sandström E; Saarimäki M
    Clin Pharmacol Ther; 1988 Jul; 44(1):65-73. PubMed ID: 2968875
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Successful foscarnet therapy for cytomegalovirus retinitis in an AIDS patient undergoing hemodialysis: rationale for empiric dosing and plasma level monitoring.
    MacGregor RR; Graziani AL; Weiss R; Grunwald JE; Gambertoglio JG
    J Infect Dis; 1991 Oct; 164(4):785-7. PubMed ID: 1654363
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The effect of foscarnet (phosphonoformate) on human immunodeficiency virus isolation, T-cell subsets and lymphocyte function in AIDS patients.
    Gaub J; Pedersen C; Poulsen AG; Mathiesen LR; Ulrich K; Lindhardt BO; Faber V; Gerstoft J; Hofmann B; Lernestedt JO
    AIDS; 1987 May; 1(1):27-33. PubMed ID: 2962590
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Determination of exifone in human plasma and urine by high-performance liquid chromatography with electrochemical detection.
    Descombe JJ; Doumont G; Picard M
    J Chromatogr; 1989 Nov; 496(2):345-53. PubMed ID: 2613838
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Foscarnet therapy for severe acyclovir-resistant herpes simplex virus type-2 infections in patients with the acquired immunodeficiency syndrome (AIDS). An uncontrolled trial.
    Erlich KS; Jacobson MA; Koehler JE; Follansbee SE; Drennan DP; Gooze L; Safrin S; Mills J
    Ann Intern Med; 1989 May; 110(9):710-3. PubMed ID: 2522751
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Treatment and prophylaxis of cytomegalovirus disease.
    Levinson ML; Jacobson PA
    Pharmacotherapy; 1992; 12(4):300-18. PubMed ID: 1325636
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Age-related differences in pharmacokinetics of phosphonoformate in cats.
    Swenson CL; Sams RA; Polas PJ; Michael DF; Mathes LE
    Antimicrob Agents Chemother; 1990 May; 34(5):871-4. PubMed ID: 2141779
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Maintenance therapy for cytomegalovirus retinitis in patients with acquired immunodeficiency syndrome: foscarnet.
    Jacobson MA
    Am J Med; 1992 Feb; 92(2A):26S-29S. PubMed ID: 1310573
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Foscarnet approved for cytomegalovirus retinitis.
    Am Fam Physician; 1991 Nov; 44(5):1890. PubMed ID: 1659165
    [No Abstract]   [Full Text] [Related]  

  • 40. Foscarnet versus ganciclovir in the management of cytomegalovirus disease in patients with AIDS.
    Minor JR
    Am J Hosp Pharm; 1991 Nov; 48(11):2478-9. PubMed ID: 1660675
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.